Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing
NCT ID: NCT00758355
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2008-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Metaphyseal Hip Prosthesis - Total Hip
NCT01501955
Bone Fixation of Mpact Double Mobility Cup
NCT02850575
ReCap Total Hip Resurfacing Prospective Data Collection
NCT00758472
Avenir® Cemented Hip Stem - PMCF
NCT03396224
Retrospective Data Review of ReCap Total Hip Resurfacing
NCT00758329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
M2A magnum
Consecutive series of patients received Total Hip Resurfacing with ReCap/Magnum
No interventions assigned to this group
Recap Magnum
Consecutive series of patients received Total Hip Replacement with ReCap/Magnum
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biomet France SARL
INDUSTRY
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Saragaglia, Pr
Role: PRINCIPAL_INVESTIGATOR
Hopital Sud - Echirolles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
CHU Pellegrin Tripode
Bordeaux, , France
CHU Hôpital Sud
Grenoble, , France
Polyclinique de Hénin Beaumont
Hénin-Beaumont, , France
Polyclinique de Riaumont
Liévin, , France
Clinique Saint Andre
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMETEU.CR.FR04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.